Only qualified professionals should handle this material in appropriate laboratory environments and in compliance with all applicable laws and regulations
The result can be damaging to lipids, proteins, and DNA [4], thus leading to subsequent infertility [5], oncogenesis, and other pathologies [6]
According to the medication procedures for obsessivecompulsive disorder of the Harvard Southbank Program, when there are both enough quantity and enough treatment with first-line drugs and conventional synergistic regimens that have poor efficacy in patients with OCD, glutamate modulators, including NAC, can be selected for use as a synergistic therapy [4]
This yields a total weekly dose of 1,500 IU
What they found: No serious adverse events triggered by AOD-9604 The most frequent side effects: headache (~5 %), occasional fatigue, at the same frequency as placebo No changes in IGF-1 levels, glycemia, blood pressure, heart rate No signals of cardiovascular, hepatic or renal toxicity Safety profile comparable to placebo Why it matters: From a safety perspective, AOD-9604 is one of the safest peptides in the clinical registry
1,2 Serum vitamin B 12 levels may be artificially elevated in patients with alcoholism, liver disease, or cancer because of decreased hepatic clearance of transport proteins and resultant higher circulating levels of vitamin B 12
